NSC |
Compound |
Enrichment |
Correlation |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0201565205286441 |
0.31350499 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0201565205286441 |
0.15283687 |
NSC 728316 |
6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0201565205286441 |
0.12908128 |
NSC 732178 |
Null |
0.0201565205286441 |
0.15934288 |
NSC 736802 |
Null |
0.0201565205286441 |
0.20369792 |
NSC 737757 |
2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole |
0.0201565205286441 |
-0.0024932886 |
NSC 740 |
Methotrexate |
0.0201565205286441 |
0.21932117 |
NSC 748712 |
Null |
0.0201565205286441 |
0.18108389 |
NSC 641245 |
Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- |
0.0203119150246197 |
0.40342805 |
NSC 644651 |
Null |
0.0203119150246197 |
0.23903404 |